{"id":"W4361958509","doi":"10.1158/1078-0432.c.6530718.v1","title":"Data from Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Lung cancer; Clinical endpoint; PARP inhibitor; Chemotherapy; Oncology; Surgery; Confidence interval; Clinical trial; Cisplatin; Biology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005892581,0.0005577137,0.001995043,0.0004845946,0.00005955436,0.00007120202,0.0002597159,0.000137235,0.00004158683],"category_scores_gemma":[0.0002488144,0.0003524904,0.00004415005,0.0003325405,0.0001671283,0.0001055053,0.001019332,0.0006547003,0.000001940472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001041405,"about_ca_system_score_gemma":0.000763387,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1383146,"about_ca_topic_score_gemma":0.1556672,"domain_scores_codex":[0.9964138,0.000411272,0.0006365427,0.001383782,0.0007069337,0.0004476554],"domain_scores_gemma":[0.9973066,0.0007335488,0.0003014704,0.001192135,0.0003109312,0.0001552636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1343644,0.004174881,0.8516068,0.0004501083,0.001737122,0.0004915281,0.005949248,0.0002374874,0.00001136779,0.00000188934,0.0001817377,0.0007934877],"study_design_scores_gemma":[0.6683677,0.002128461,0.3120237,0.001281787,0.001285364,2.790638e-7,0.00224119,0.01219064,0.00007096008,0.00001693114,0.00001323351,0.0003796814],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813589,0.001434308,0.00007194393,0.0004281015,0.0001062626,0.01487031,0.001392576,0.00008288456,0.0002546515],"genre_scores_gemma":[0.9910517,0.00119749,0.0005930205,0.00004940226,0.00004302006,0.002571302,0.003151647,0.00008640458,0.00125597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5395831,"threshold_uncertainty_score":0.9998927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06618949606572638,"score_gpt":0.3835364755736122,"score_spread":0.3173469795078858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}